Prolonged SARS-CoV-2 Infection in a CAR T-Cell Therapy Recipient.

作者信息

Abbasi Jennifer

出版信息

JAMA. 2021 Mar 9;325(10):924. doi: 10.1001/jama.2021.2493.

DOI:10.1001/jama.2021.2493

PMID:33687450

Abstract

摘要

相似文献

Prolonged SARS-CoV-2 Infection in a CAR T-Cell Therapy Recipient.

JAMA. 2021 Mar 9;325(10):924. doi: 10.1001/jama.2021.2493.

The burden of SARS-CoV-2 in patients receiving chimeric antigen receptor T cell immunotherapy: everything to lose.

Expert Rev Anti Infect Ther. 2022 Sep;20(9):1155-1162. doi: 10.1080/14787210.2022.2101448. Epub 2022 Jul 22.

Severe presentations and high mortality from SARS-CoV-2 in patients undergoing chimeric antigen receptor (CAR-T) therapy: a UK NCCP analysis.

Leuk Lymphoma. 2022 Aug;63(8):1980-1984. doi: 10.1080/10428194.2022.2057487. Epub 2022 Apr 28.

Case Report: Convalescent Plasma Therapy Induced Anti-SARS-CoV-2 T Cell Expansion, NK Cell Maturation and Virus Clearance in a B Cell Deficient Patient After CD19 CAR T Cell Therapy.

Front Immunol. 2021 Aug 12;12:721738. doi: 10.3389/fimmu.2021.721738. eCollection 2021.

COVID-19 after hematopoietic cell transplantation and chimeric antigen receptor (CAR)-T-cell therapy.

Transpl Infect Dis. 2023 Nov;25 Suppl 1:e14144. doi: 10.1111/tid.14144. Epub 2023 Sep 28.

SARS-CoV-2 variants and convalescent plasma: reality, fallacies, and opportunities.

J Clin Invest. 2021 Apr 1;131(7). doi: 10.1172/JCI148832.

Anti-BCMA CAR T administration in a relapsed and refractory multiple myeloma patient after COVID-19 infection: a case report.

J Med Case Rep. 2021 Feb 19;15(1):90. doi: 10.1186/s13256-020-02598-0.

Rapid recovery of taste and smell in a patient with SARS-CoV-2 following convalescent plasma therapy.

QJM. 2021 Aug 29;114(5):319-320. doi: 10.1093/qjmed/hcaa341.

Neutralisation of circulating SARS-CoV-2 delta and omicron variants by convalescent plasma and SARS-CoV-2 hyperimmune intravenous human immunoglobulins for treatment of COVID-19.

Ann Rheum Dis. 2022 Jul;81(7):1044-1045. doi: 10.1136/annrheumdis-2022-222115. Epub 2022 Feb 10.

[Is convalescent plasma an alternative treatment for Covid-19 patients?].

Salud Publica Mex. 2020 Nov-Dec;62(6):870-871. doi: 10.21149/11744.

引用本文的文献

Inactivated vaccine dosage and serum IgG levels correlate with persistent COVID-19 infections in hematologic malignancy patients during the Omicron Surge in China.

BMC Infect Dis. 2024 Oct 11;24(1):1141. doi: 10.1186/s12879-024-10063-2.

Essentials of CAR-T Therapy and Associated Microbial Challenges in Long Run Immunotherapy.

J Cell Immunol. 2024;6(1):22-50. doi: 10.33696/immunology.6.189.

Infectious complications of CAR T-cell therapy: a clinical update.

Ther Adv Infect Dis. 2021 Aug 24;8:20499361211036773. doi: 10.1177/20499361211036773. eCollection 2021 Jan-Dec.

Severe COVID-19 in patients with hematological cancers presenting with viremia.

Ann Oncol. 2021 Oct;32(10):1297-1300. doi: 10.1016/j.annonc.2021.07.002. Epub 2021 Jul 13.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Suppr
超能文献

Prolonged SARS-CoV-2 Infection in a CAR T-Cell Therapy Recipient.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

Suppr超能文献

Prolonged SARS-CoV-2 Infection in a CAR T-Cell Therapy Recipient.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

Suppr
超能文献